Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 2/20 | 0.33 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.32 |
| ▸ | AMY2A | P04746 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 4/20 | 0.32 |
| ▸ | SI | P14410 | 4/20 | 0.32 |
| ▸ | OGA | O60502 | 1/20 | 0.32 |
| ▸ | PYGB | P11216 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8368157 | 0.85 | LGALS8 (0.36) | LGALS8OGAPYGB | |
| SCHEMBL1870755 | 0.85 | LGALS8 (0.36) | LGALS8OGAPYGB | |
| SCHEMBL6261875 | 0.79 | CD69 (0.42) | LGALS8PYGB | |
| SCHEMBL5183891 | 0.77 | — | — | |
| SCHEMBL348997 | 0.77 | — | — | |
| SCHEMBL393237 | 0.77 | — | — | |
| SCHEMBL329683 | 0.77 | — | — | |
| SCHEMBL1607814 | 0.77 | — | — | |
| SCHEMBL532553 | 0.77 | — | — | |
| SCHEMBL3623222 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019163943-A1 | MEDICINAL COMPOSITION | 公益財団法人川崎市産業振興財団 | 2019-08-29 | — | — | WO | claimed |
| US-10220026-B2 | Micelle containing epirubicin-complexed block copolymer and anti-cancer agent, and pharmaceutical composition containing said micelle applicable to treatment of cancer, resistant cancer or metastatic cancer | THE UNIVERSITY OF TOKYO (JP) | 2019-03-05 | — | — | US | claimed |
| US-20170258922-A1 | MICELLE CONTAINING EPIRUBICIN-COMPLEXED BLOCK COPOLYMER AND ANTI-CANCER AGENT, AND PHARMACEUTICAL COMPOSITION CONTAINING SAID MICELLE APPLICABLE TO TREATMENT OF CANCER, RESISTANT CANCER OR METASTATIC CANCER | THE UNIVERSITY OF TOKYO (JP) | 2017-09-14 | — | — | US | claimed |
| EP-3181136-A1 | MICELLE CONTAINING EPIRUBICIN-COMPLEXED BLOCK COPOLYMER AND ANTI-CANCER AGENT, AND PHARMACEUTICAL COMPOSITION CONTAINING SAID MICELLE APPLICABLE TO TREATMENT OF CANCER, RESISTANT CANCER OR METASTATIC CANCER | The University of Tokyo (JP) | 2017-06-21 | — | — | EP | claimed |
| CN-113939192-B | Controlled release biodegradable core-shell microcapsule compositions | 国际香料和香精公司 | 2023-08-11 | — | — | CN | disclosed |
| CN-110997081-B | Surfactant mixtures, compositions comprising them and their use in foam concentrates for fire extinguishing | 化工产品开发公司SEPPIC | 2022-03-15 | — | — | CN | disclosed |
| CN-110249038-B | Novel surfactant mixtures, novel compositions comprising the same and their use in foam concentrates for extinguishing fires | 化工产品开发公司SEPPIC | 2021-11-26 | — | — | CN | disclosed |
| WO-2019163943-A1 | MEDICINAL COMPOSITION | 公益財団法人川崎市産業振興財団 | 2019-08-29 | — | — | WO | disclosed |
| WO-2019163943-A1 | MEDICINAL COMPOSITION | 公益財団法人川崎市産業振興財団 | 2019-08-29 | — | — | WO | disclosed |
| US-10220026-B2 | Micelle containing epirubicin-complexed block copolymer and anti-cancer agent, and pharmaceutical composition containing said micelle applicable to treatment of cancer, resistant cancer or metastatic cancer | THE UNIVERSITY OF TOKYO (JP) | 2019-03-05 | — | — | US | disclosed |
| US-20170258922-A1 | MICELLE CONTAINING EPIRUBICIN-COMPLEXED BLOCK COPOLYMER AND ANTI-CANCER AGENT, AND PHARMACEUTICAL COMPOSITION CONTAINING SAID MICELLE APPLICABLE TO TREATMENT OF CANCER, RESISTANT CANCER OR METASTATIC CANCER | THE UNIVERSITY OF TOKYO (JP) | 2017-09-14 | — | — | US | disclosed |
| EP-3181136-A1 | MICELLE CONTAINING EPIRUBICIN-COMPLEXED BLOCK COPOLYMER AND ANTI-CANCER AGENT, AND PHARMACEUTICAL COMPOSITION CONTAINING SAID MICELLE APPLICABLE TO TREATMENT OF CANCER, RESISTANT CANCER OR METASTATIC CANCER | The University of Tokyo (JP) | 2017-06-21 | — | — | EP | disclosed |
| US-20120276596-A1 | MODIFIED BIOMATERIAL, USES THEREOF AND MODIFICATION METHODS | TEKNOLOGIAN TUTKIMUSKESKUS VTT (FI) | 2012-11-01 | — | — | US | disclosed |
| EP-2513152-A1 | MODIFIED BIOMATERIAL, USES THEREOF AND MODIFICATION METHODS | Teknologian tutkimuskeskus VTT (FI) | 2012-10-24 | — | — | EP | disclosed |
| CN-102666825-A | Cleaning composition comprising hemicellulose | PROCTER & GAMBLE | 2012-09-12 | — | — | CN | disclosed |
| US-20110152165-A1 | Cleaning Composition Containing Hemicellulose | PROCTER & GAMBLE COMPANY, THE | 2011-06-23 | — | — | US | disclosed |
| WO-2011075352-A1 | CLEANING COMPOSITION CONTAINING HEMICELLULOSE | THE PROCTER & GAMBLE COMPANY (US) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011073522-A1 | MODIFIED BIOMATERIAL, USES THEREOF AND MODIFICATION METHODS | TEKNOLOGIAN TUTKIMUSKESKUS VTT (FI) | 2011-06-23 | — | — | WO | disclosed |
| EP-2336283-A1 | Cleaning composition containing hemicellulose | The Procter & Gamble Company (US) | 2011-06-22 | — | — | EP | disclosed |
| JP-2005021046-A | ENDO-beta-(1->6)-GALACTANASE | JAPAN SCIENCE & TECHNOLOGY AGENCY | 2005-01-27 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170258922-A1 | MICELLE CONTAINING EPIRUBICIN-COMPLEXED BLOCK COPOLYMER AND ANTI-CANCER AGENT, AND PHARMACEUTICAL COMPOSITION CONTAINING SAID MICELLE APPLICABLE TO TREATMENT OF CANCER, RESISTANT CANCER OR METASTATIC CANCER | ABCC1, ABCB1, TOP2A | LGALS8 3175/4885SLC5A2 3873/4885AMY2A 2350/4885 |
| US-10220026-B2 | Micelle containing epirubicin-complexed block copolymer and anti-cancer agent, and pharmaceutical composition containing said micelle applicable to treatment of cancer, resistant cancer or metastatic cancer | ABCC1, ABCB1, TOP2A | LGALS8 3175/4885SLC5A2 3873/4885AMY2A 2350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.